Advertisement

Chronic Cough and Acute Wheezing

  • Juan J. L. Sienra-Monge
  • Jaime M. Del-Rio-Chivardi
  • Elsy M. Navarrete-Rodríguez
Chapter

Practical Points

  • Asthma is the most frequent chronic inflammatory lung disease of childhood

  • Exacerbations should be treated with short acting beta-2 agonist and systemic steroids

  • Long-term control should be based on the symptoms prior to the crisis

  • When the patient first presents with acute exacerbation with no history of disease severity prior to the attack, treatment should at least start on level 3 (Tebo et al., Pediatr Rheumatol Online J 10:29, 2012; Adkinson and Middleton, Middleton’s allergy: principles and practice, 2013; Castro-Rodriguez et al., Am J Respir Crit Care Med 162(4 Pt 1):1403–6, 2006; Larenas-Linnemann et al., Rev Alerg Mex. 64(Suppl 1):s11-s128, 2017).

Keywords

Asthma attack Salmeterol Budesonide Salbutamol Ipratropium 

References

  1. 1.
    Tebo AE, Jaskowski T, Davis KW, Whiting A, Clifford B, Zeft A, McNally B, Hill HR, Bohnsack J, Prahalad S. Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2012;10:29.CrossRefGoogle Scholar
  2. 2.
    Adkinson NF, Middleton E. Middleton’s allergy: principles and practice. 8th ed. Amsterdam: Elsevier; 2013.Google Scholar
  3. 3.
    Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162(4. Pt 1):1403–6.CrossRefGoogle Scholar
  4. 4.
    Larenas-Linnemann D, Salas-Hernandez J, Vazquez-Garcia JC, Ortiz-Aldana I, Fernandez-Vega M, Del Rio-Navarro BE, MDC C-S, Luna-Pech JA, Ortega-Martell JA, Romero-Lombard J, EDC L-E, Villaverde-Rosas J, Mayorga-Butron JL, Vargas-Becerra MH, Bedolla-Barajas M, Rodriguez-Perez N, Aguilar-Aranda A, Jimenez-Gonzalez CA, Garcia-Bolanos C, Garrido-Galindo C, Mendoza-Hernandez DA, Mendoza-Lopez E, Lopez-Perez G, Wakida-Kuzonoki GH, Ruiz-Gutierrez HH, Leon-Molina H, Martinez-De la Lanza H, Stone-Aguilar H, Gomez-Vera J, Olvera-Salinas J, Oyoqui-Flores JJ, Galvez-Romero JL, Lozano-Saenz JS, Salgado-Gama JI, Jimenez-Chobillon MA, Garcia-Aviles MA, Guinto-Balanzar MP, Medina-Avalos MA, Camargo-Angeles R, Garcia-Torrentera R, Toral-Freyre S, Montes-Narvaez G, Solorio-Gomez H, Rosas-Pena J, Romero-Tapia SJ, Reyes-Herrera A, Cuevas-Schacht F, Esquer-Flores J, Sacre-Hazouri JA, Compean-Martinez L, Medina-Sanchez PJ, Garza-Salinas S, Baez-Loyola C, Romero-Alvarado I, Miguel-Reyes JL, Huerta-Espinosa LE, Correa-Flores MA, Castro-Martinez R. Mexican asthma guidelines: GUIMA 2017. Rev Alerg Mex. 2017;64(Suppl 1):s11–s128.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Juan J. L. Sienra-Monge
    • 1
  • Jaime M. Del-Rio-Chivardi
    • 1
  • Elsy M. Navarrete-Rodríguez
    • 1
  1. 1.Hospital Infantil de México Federico GómezCiudad de MéxicoMexico

Personalised recommendations